Autoimmunity BioSolutions
PrivateLast Round
Seed
May 6, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autoimmunity BioSolutions is a biotechnology company developing a next-generation, immuno-corrective antibody therapy for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autoimmunity BioSolutions Comparables
Compare Autoimmunity BioSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbolerIS Pharma | 78% | |
| Anokion | 76% | |
| Equillium Inc. | 76% |
Autoimmunity BioSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2026 |
Key People
Founding team and executive leadership
Autoimmunity BioSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NewTech Investment Holdings | Seed |
| Alexandria Venture Investments | Seed |
| Independent Capital Group | Seed |
| Eos | Seed |
| Independence Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 1646% MoM, reaching 1.2K.
- May 6, 2026
Raised $3.2M in Seed funding.
Autoimmunity BioSolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Autoimmunity BioSolutions's valuation, stock price, and market status.
Is Autoimmunity BioSolutions a public or private company?
Autoimmunity BioSolutions is a private company.
What is the current stock price of Autoimmunity BioSolutions?
Autoimmunity BioSolutions is a private company with no public stock price. No recent secondary market data is available.
How much is Autoimmunity BioSolutions worth (valuation)?
Valuation information for Autoimmunity BioSolutions is not publicly available.
Can I buy Autoimmunity BioSolutions stock?
Autoimmunity BioSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Autoimmunity BioSolutions's last funding round?
Autoimmunity BioSolutions's most recent funding round was Seed on May 6, 2026.
Who are the main investors in Autoimmunity BioSolutions?
Key investors in Autoimmunity BioSolutions include Eos.
Will Autoimmunity BioSolutions IPO soon?
No public IPO plans have been announced for Autoimmunity BioSolutions.
How can I track Autoimmunity BioSolutions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Autoimmunity BioSolutions's secondary market activity and sign up for updates.